Post your job infront of 100,000+ qualified LP's and GP's.
Portfolio Manager Jobs in London
Recently Filled Jobs
Firms you might be interested in
Posted on: July 8, 2019, 9:11 p.m.
Seattle biotech startup OncoSenX has reeled in $3 million to advance its pipeline of therapeutics that aim to kill cancer cells based on their genetics. OncoSenX’s technology targets solid tumors based on a patented lipid nanoparticle gene delivery system and a highly targeted DNA payload. The company claims that its approach is “a less invasive, more precise intervention” of cancer therapy. OncoSenX is a spinout out of Oisin Biotechnologies, a 5-year-old Seattle company led by veteran biotech entrepreneur Matthew Scholz, ... Full investment news articleRelevent to this post: Louisiana Economic Development,